The presence of increased amounts of the matrix component fibronectin together with alveolar macrophage-derived growth factor within the alveolar structures of patients with fibrotic lung disease may play a significant role in the fibrosis characteristic of these disorders, by amplifying the numbers of fibroblasts in the alveolar structures of these patients.
|Issue number||5 Suppl.|
|Publication status||Published - 1 Jan 1983|
ASJC Scopus subject areas
- Pulmonary and Respiratory Medicine
- Critical Care and Intensive Care Medicine
- Cardiology and Cardiovascular Medicine